Supplementary Figure 5 from PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells

Supplementary Figure 5 from PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells

<p>Supplementary Figure 5</p>

Сохранить в:

Библиографические подробности
Главный автор:	Francisco Exposito (16721403) (author)
Другие авторы:	Miriam Redrado (16721406) (author), Maeva Houry (16721409) (author), Katherine Hastings (16721412) (author), Magdalena Molero-Abraham (16721415) (author), Teresa Lozano (16721418) (author), Jose Luis Solorzano (16721421) (author), Julian Sanz-Ortega (16721424) (author), Vera Adradas (16721427) (author), Ramon Amat (16721430) (author), Esther Redin (16721433) (author), Sergio Leon (16721436) (author), Naroa Legarra (16721439) (author), Javier Garcia (16721442) (author), Diego Serrano (16721445) (author), Karmele Valencia (14962695) (author), Camila Robles-Oteiza (16721448) (author), Giorgia Foggetti (15118568) (author), Nerea Otegui (16721451) (author), Enriqueta Felip (16721454) (author), Juan J. Lasarte (16721457) (author), Luis Paz-Ares (16721460) (author), Jon Zugazagoitia (16721463) (author), Katerina Politi (15313362) (author), Luis Montuenga (16721466) (author), Alfonso Calvo (16721469) (author)
Опубликовано:	2025
Предметы:	Cancer Cancer Biology Immuno-oncology Immunotherapy Combination immunotherapy Lung Cancer Oncogenes & Tumor Suppressors PD-1
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!

Схожие документы

Supplementary Figure 1 from PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells
по: Francisco Exposito (16721403)
Опубликовано: (2025)

Supplementary Figure 2 from PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells
по: Francisco Exposito (16721403)
Опубликовано: (2025)

Supplementary Figure 3 from PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells
по: Francisco Exposito (16721403)
Опубликовано: (2025)

Supplementary Figure 4 from PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells
по: Francisco Exposito (16721403)
Опубликовано: (2025)

Processed single-cell RNA-seq dataset of cancer-associated fibroblasts in breast cancer patients receiving anti–PD-1 therapy
по: Thang Pham (19938126)
Опубликовано: (2025)

Supplementary Table 1 from Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1
по: Caroline Robert (15032672)
Опубликовано: (2025)

Supplementary Table 2 from Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1
по: Caroline Robert (15032672)
Опубликовано: (2025)

Supplementary Table 3 from Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1
по: Caroline Robert (15032672)
Опубликовано: (2025)

Supplementary Table 4 from Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1
по: Caroline Robert (15032672)
Опубликовано: (2025)

Data Sheet 3_Integrated liquid biopsy model for predicting metastasis and guiding PD-1 therapy in esophageal squamous cell carcinoma.pdf
по: Hailong Pang (12841991)
Опубликовано: (2025)

Data Sheet 2_Integrated liquid biopsy model for predicting metastasis and guiding PD-1 therapy in esophageal squamous cell carcinoma.pdf
по: Hailong Pang (12841991)
Опубликовано: (2025)

Data Sheet 1_Integrated liquid biopsy model for predicting metastasis and guiding PD-1 therapy in esophageal squamous cell carcinoma.pdf
по: Hailong Pang (12841991)
Опубликовано: (2025)

Supplementary Table S1 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
по: Hansol Lee (15054787)
Опубликовано: (2025)

Supplementary Table S2 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
по: Hansol Lee (15054787)
Опубликовано: (2025)

Supplementary Table S3 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
по: Hansol Lee (15054787)
Опубликовано: (2025)

Supplementary Table S4 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
по: Hansol Lee (15054787)
Опубликовано: (2025)

File_S1 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
по: Stéphane Fattori (15048281)
Опубликовано: (2025)

Table S1 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
по: Stéphane Fattori (15048281)
Опубликовано: (2025)

Table S2 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
по: Stéphane Fattori (15048281)
Опубликовано: (2025)

Table S3 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
по: Stéphane Fattori (15048281)
Опубликовано: (2025)

Table S4 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
по: Stéphane Fattori (15048281)
Опубликовано: (2025)

Table S5 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
по: Stéphane Fattori (15048281)
Опубликовано: (2025)

Table S6 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
по: Stéphane Fattori (15048281)
Опубликовано: (2025)

Table S7 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
по: Stéphane Fattori (15048281)
Опубликовано: (2025)

Table S8 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
по: Stéphane Fattori (15048281)
Опубликовано: (2025)

Table S2, S4, S5, S6 and S7 from Single-Cell Analysis Reveals a CD4<sup>+</sup> T-cell Cluster That Correlates with PD-1 Blockade Efficacy
по: Hiroshi Kagamu (14961732)
Опубликовано: (2025)

Supplementary Figure S1 from Phase II Trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody-Armed Activated T Cells in Metastatic Castration-Resistant Prostate Cancer
по: Ulka N. Vaishampayan (15051039)
Опубликовано: (2025)

Supplementary Figure S2 from Phase II Trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody-Armed Activated T Cells in Metastatic Castration-Resistant Prostate Cancer
по: Ulka N. Vaishampayan (15051039)
Опубликовано: (2025)

Supplementary Figure S3 from Phase II Trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody-Armed Activated T Cells in Metastatic Castration-Resistant Prostate Cancer
по: Ulka N. Vaishampayan (15051039)
Опубликовано: (2025)

Supplementary Table S2 from Phase II Trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody-Armed Activated T Cells in Metastatic Castration-Resistant Prostate Cancer
по: Ulka N. Vaishampayan (15051039)
Опубликовано: (2025)

Supplementary File 1 from Cetuximab Responses in Patients with HNSCC Correlate to Clonal Expansion Feature of Peripheral and Tumor-Infiltrating T Cells with Top T-Cell Receptor Clonotypes
по: Huaibin Ge (15047462)
Опубликовано: (2025)

Datasets for bibliometric analysis of regulatory T cells in gastric cancer (2005-2025)
по: Houshu Tu (22026668)
Опубликовано: (2025)

TS1-9 from Dynamics of Sequence and Structural Cell-Free DNA Landscapes in Small-Cell Lung Cancer
по: Lavanya Sivapalan (15314248)
Опубликовано: (2025)

Supplementary Figure S1 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
по: Rohit Thummalapalli (17314483)
Опубликовано: (2025)

Supplementary Figure S10 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
по: Rohit Thummalapalli (17314483)
Опубликовано: (2025)

Supplementary Figure S11 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
по: Rohit Thummalapalli (17314483)
Опубликовано: (2025)

Supplementary Figure S12 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
по: Rohit Thummalapalli (17314483)
Опубликовано: (2025)

Supplementary Figure S13 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
по: Rohit Thummalapalli (17314483)
Опубликовано: (2025)

Supplementary Figure S14 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
по: Rohit Thummalapalli (17314483)
Опубликовано: (2025)

Supplementary Figure S15 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
по: Rohit Thummalapalli (17314483)
Опубликовано: (2025)

Cannot write session to /tmp/vufind_sessions/sess_6e6nuj4el1969mmb76tfeajfts